These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Specific immunity to human papilloma virus (HPV) in patients with genital warts. Viac J; Staquet MJ; Miguet M; Chabanon M; Thivolet J Br J Vener Dis; 1978 Jun; 54(3):172-5. PubMed ID: 207383 [TBL] [Abstract][Full Text] [Related]
68. Distinctive distribution of human papillomavirus type 16 and type 20 DNA in the tonsillar and the skin carcinomas of a patient with epidermodysplasia verruciformis. Ishiji T; Kawase M; Honda M; Niimura M; Yoshimura E; Sata T; Matsukura T Br J Dermatol; 2000 Nov; 143(5):1005-10. PubMed ID: 11069510 [TBL] [Abstract][Full Text] [Related]
69. High frequency of detection of human papillomaviruses associated with epidermodysplasia verruciformis in children with psoriasis. Mahé E; Bodemer C; Descamps V; Mahé I; Crickx B; De Prost Y; Favre M Br J Dermatol; 2003 Oct; 149(4):819-25. PubMed ID: 14616375 [TBL] [Abstract][Full Text] [Related]
70. Epidermodysplasia verruciformis as a model in studies on the role of papovaviruses in oncogenesis. Jablonska S; Dabrowski J; Jakubowicz K Cancer Res; 1972 Mar; 32(3):583-9. PubMed ID: 5061309 [No Abstract] [Full Text] [Related]
71. A novel human papillomavirus identified in epidermodysplasia verruciformis. Harris AJ; Purdie K; Leigh IM; Proby C; Burge S Br J Dermatol; 1997 Apr; 136(4):587-91. PubMed ID: 9155964 [TBL] [Abstract][Full Text] [Related]
72. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis. Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952 [TBL] [Abstract][Full Text] [Related]
73. A genotype distribution of human papillomaviruses detected by polymerase chain reaction and direct sequencing analysis in a large sample of common warts in Japan. Hagiwara K; Uezato H; Arakaki H; Nonaka S; Nonaka K; Nonaka H; Asato T; Oshiro M; Kariya K; Hattori A J Med Virol; 2005 Sep; 77(1):107-12. PubMed ID: 16032719 [TBL] [Abstract][Full Text] [Related]
74. Human papillomavirus infection and skin cancer risk in organ transplant recipients. Bouwes Bavinck JN; Feltkamp M; Struijk L; ter Schegget J J Investig Dermatol Symp Proc; 2001 Dec; 6(3):207-11. PubMed ID: 11924829 [TBL] [Abstract][Full Text] [Related]
75. The virus of epidermodysplasia verruciformis: electron microscopic and fluorescent antibody studies. Yabe Y; Sadakane H J Invest Dermatol; 1975 Sep; 65(3):324-30. PubMed ID: 808576 [TBL] [Abstract][Full Text] [Related]
76. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. Pereira de Oliveira WR; Carrasco S; Neto CF; Rady P; Tyring SK J Dermatol; 2003 Mar; 30(3):203-9. PubMed ID: 12692356 [TBL] [Abstract][Full Text] [Related]
77. Tissue effects of and host response to human papillomavirus infection. Jenson AB; Kurman RJ; Lancaster WD Dermatol Clin; 1991 Apr; 9(2):203-9. PubMed ID: 1647900 [TBL] [Abstract][Full Text] [Related]
78. Do epidermodysplasia verruciformis human papillomaviruses contribute to malignant and benign epidermal proliferations? Majewski S; Jablonska S Arch Dermatol; 2002 May; 138(5):649-54. PubMed ID: 12020228 [TBL] [Abstract][Full Text] [Related]
79. Human papillomavirus (HPV) types specific of epidermodysplasia verruciformis detected in warts induced by HPV3 or HPV3-related types in immunosuppressed patients. Obalek S; Favre M; Szymanczyk J; Misiewicz J; Jablonska S; Orth G J Invest Dermatol; 1992 Jun; 98(6):936-41. PubMed ID: 1317396 [TBL] [Abstract][Full Text] [Related]
80. Psoriasis: A possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. Favre M; Orth G; Majewski S; Baloul S; Pura A; Jablonska S J Invest Dermatol; 1998 Apr; 110(4):311-7. PubMed ID: 9540967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]